August 27, 2014 1:08 PM ET

Pharmaceuticals

Company Overview of Eyetech Inc.

Company Overview

Eyetech Inc., a biotechnology company, develops products for the treatment of sight-threatening diseases of the retina. It offers Macugen, a pegaptanib sodium injection/anti-VEGF inhibitor that is used for the treatment of neovascular age-related macular degeneration. The company also offers Macugen access programs that assist patients with reimbursement. It markets and sells Macugen in the United States. Eyetech Inc. was founded in 2008 and is based in Cedar Knolls, New Jersey. As of February 13, 2012, Eyetech Inc. operates as a subsidiary of Valeant Pharmaceuticals International, Inc.

140 East Hanover Avenue

Cedar Knolls, NJ 07927

United States

Founded in 2008

Phone:

973-539-6009

Key Executives for Eyetech Inc.

Co-Founder and President
Executive Chairman
Age: 60
Co-Founder and Executive Vice President Quality Assurance & Quality Control
Chairman of Valeant Pharmaceuticals International Inc and Chief Executive Officer of Valeant Pharmaceuticals International Inc
Age: 54
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Receptor Logic, Inc. United States
Integris Global, L.P. United States
Green Cures Inc. United States
Angelini Pharma, Inc. United States
Perrigo Holland, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Eyetech Inc., please visit www.eyetech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.